Pharmaceutical Pricing
I would suggest separate categories for medicines, medical devices, common consumables etc. Within those, sub categories will have to be decided such as tablets, capsules, oral liquids, injectibles and depending upon degree of sophistication (and investment) required to manufacture, profit margins can be decided.
The medicines which are patented by the manufacturers (those 1% or less) will have to have different margins / free pricing for a stipulated period as these have gone through a very long gestation period and costs involved are very high.
Combination formulations which are made primarily to escape price control should be brought under pricing mechanism.
Presently, as per Drug Price Control Order (DPCO) a manufacturer is permitted 100% margin over manufacturing costs. Also, a price increase of 10% per year is admissible.
The present pricing formula adopted by Drug Control Authorities, based on average prices of different companies, is absurd.
We can keep discussing this however I don't see any willingness on the part of the Government to bring in strict pricing mechanism at least till the next general elections. more